Donna Young's profile photo

Donna Young

Washington, D.C.

Senior Reporter at S&P Global

Joyful 'freed' journalist - formerly covered FDA/CDC/NIH/pharma/biotech - 'The pharma diviner'🔬 https://t.co/JuCX17fdtM 🧵@dcdonnayoung

Articles

  • 2 weeks ago | lookout.co | Anita Aguirre |Donna Young |Laura Marcus |Stephen Gray

    Quick Take Four local health care leaders applaud the Santa Cruz County Board of Supervisors, particularly newly minted Supervisor Monica Martinez, for urging state leaders to protect Medi-Cal funding in the 2025-26 budget.

  • Oct 16, 2024 | insights.citeline.com | Donna Young

    Anavex Thumped On SEC Subpoena, Probe29 Dec 2015 • By Donna YoungShares of Anavex Life Sciences Corp. were smacked on Dec. 29 – tumbling as low as 21.2% in morning trading – after the company revealed it had been hit with a subpoena from the Securities and Exchange Commission (SEC) declaring it was conducting a formal investigation of the firm.

  • Oct 15, 2024 | insights.citeline.com | Donna Young

    US Capitol Capsule: What to do about inter partes reviews? Reforming reforms06 Jul 2015 • By Donna YoungWith 4th of July vacations over, the trade groups representing the biopharmaceutical industry are gearing up for their next big fight in Washington – changing the path of a patent reform bill, The Innovation Act (HR 9), which is expected to be voted on this month by the US House.

  • Oct 15, 2024 | insights.citeline.com | Donna Young

    US Capitol Capsule: 'Innovative' Value-Based Pricing Strategies: Biopharma's Savior?

  • Oct 15, 2024 | insights.citeline.com | Donna Young

    Amgen's PCSK9 Patent Win: A Long-Term Value Shift? 17 Mar 2016 • By Donna YoungAmgen Inc. may have won a battle in its lawsuit involving two patents on its proprotein convertase subtilisin/kexin 9 (PCSK9) inhibitor Repatha (evolocumab) against Sanofi SA and Regeneron Pharmaceuticals Inc., which market a competing drug, Praluent (alirocumab), but the California biotech giant is far from winning the war – that is, making the prophesied blockbuster profits on its medicine.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
9K
Tweets
286K
DMs Open
No
DonnaYoungDC
DonnaYoungDC @DonnaYoungDC
23 Mar 25

RT @LHSummers: @SecScottBessent, you have no more important national security or economic responsibility than assuring that the nation’s ta…

DonnaYoungDC
DonnaYoungDC @DonnaYoungDC
23 Mar 25

RT @LHSummers: Revenues losses would increase over time because tax cheating is highly contagious, and deficits would spiral even further o…

DonnaYoungDC
DonnaYoungDC @DonnaYoungDC
23 Mar 25

RT @LHSummers: If we lose anything like the 10 percent of IRS revenue forecast here the economic consequences could be catastrophic. https:…